-
Correction to: Therapeutic strategies for multi-resistant Escherichia coli in urinary tract infections—a cause for concern
-
Carbapenem resistance in community-acquired urinary tract infections caused by Klebsiella pneumoniae and Escherichia coli in Morocco: a multicentre study (January 2022–December 2023)‘Carbapenem resistance in community UTIs in Morocco’
-
Bacteremic versus Non-Bacteremic Urinary Tract Infections: Predictors of Poor Clinical Outcome
-
Pharmacokinetic analysis of nacubactam, a novel β-lactamase inhibitor, co-administered with meropenem in patients with a complicated urinary tract infection
-
A study of urinary tract infections in renal transplant patients
-
Prognosis prediction by urinary liver-type fatty acid-binding protein in patients in the intensive care unit admitted from the emergency department: A single-center, historical cohort study
-
A Case of Ileal Conduit Bleeding Caused by Porto‐Sinusoidal Vascular Disorder
-
Molecular epidemiology of Escherichia coli isolated from urinary tract infections in inpatients and outpatients in Gauteng, South Africa
-
Clinical features and hematological indices predicting all-cause mortality in patients undergoing hemodialysis; a retrospective cohort study
-
The Utility of Sex-Specific Cut-offs for High-Sensitivity Troponin T for Long-Term All-cause Mortality Risk Assessment in Heart Failure
-
Pancreatic stone protein predicts hospital stay in community-acquired infections
-
29 | RNA-based combinatorial multi-target therapy for the treatment of Duchenne muscular dystrophy
-
One Health approach to characterize antimicrobial resistance in Morganella morganii in humans, freshwater fish and pigs
-
26 | Validation of a new multi-target antioxidant treatment for the therapy of Duchenne muscular dystrophy
-
Unity makes strength: multi-wire technique for bailout sheath upsizing during endovascular revascularisations
-
Evolving strategies in pulmonary arteriovenous malformation embolization
-
Infection prevention in total knee arthroplasty: current concepts, controversies, and a clinical algorithm
-
Adverse event severity in weekend and after-hours interventional radiology: a multi-institutional quality review
-
The WHO costing and budgeting tool for national action plans on antimicrobial resistance—a review and assessment of impact in Africa
-
Governance of antimicrobial resistance in Central Africa (2015–2025): a systematic review of policies, One Health coordination and funding
-
In vitro activity of the novel β-lactamase inhibitor nacubactam against a nationwide collection of carbapenem-resistant Enterobacterales in Japan
-
Ribavirin at the Era of Novel Direct Antiviral Agents for the Treatment of Hepatitis C Virus Infection: Relevance of Pharmacological Monitoring
-
Hepatitis B Virus Infection and the Kidney: Renal Abnormalities in HBV Patients, Antiviral Drugs Handling, and Specific Follow-Up
-
Patients referred to but not taken on to an outpatient parenteral antimicrobial therapy (OPAT) service: the impact of infection specialist advice on the assessment and clinical outcomes
